Albany – NY, Oct. 21, 2015 (GLOBE NEWSWIRE) — The featured report on Transparency Market Research, titled “Active Pharmaceutical Ingredients (API) Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020“, offers key insights into the market. According to the report, the global active pharmaceuticals ingredients (APIs) market will expand at a moderate CAGR of 6.5% during the forecast period from 2014 to 2020. In 2013, the global active pharmaceuticals ingredients market was valued at US$119.7 bn and by 2020, the market is projected to be worth US$185.9 bn.
Browse the full Active Pharmaceutical Ingredients (API) Market: (Branded/Generic/Over-the-counter, Chemical/Biological, Captive/Contract Manufactured, by Geography, and by Therapeutic Area) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020 report at http://www.transparencymarketresearch.com/active-pharmaceutical-ingredients.html
The global active pharmaceuticals ingredients (APIs) market is driven by the rising abbreviated new drug applications (ANDA). In the past few years, the growth in ANDAs has in turn fuelled the demand for APIs. In addition to this, the growth in filing drug master files (DMFs) from several Indian firms has fueled the overall APIs market. On the other hand, the global active pharmaceuticals ingredients market will be constrained by the strict European Union regulatory policies.
On the basis of manufacturing types, the global active pharmaceuticals ingredients (APIs) market is segmented into API contract manufacturing and captive or in-house API manufacturing. The captive or in-house API manufacturing sector is dominating the global active pharmaceuticals ingredients market. Nevertheless, this sector is projected to lose ground to the API contract manufacturing sector in the coming few years due to increased competition.
By type, the global active pharmaceuticals ingredients (APIs) market is divided into biological API and synthetic chemical API. Several major pharmaceutical companies in the global active pharmaceuticals ingredients market are focusing extensively on the development of biological APIs, which is projected to drive this segment significantly.
On the basis of drug types, the global active pharmaceuticals ingredients (APIs) market is divided into over-the-counter drugs, generic prescription drugs, and branded or innovative prescription drugs. At present, the generic prescription drugs segment is leading the global active pharmaceuticals ingredients market.By therapeutic area, the global active pharmaceuticals ingredients (APIs) market is classified into musculoskeletal drugs, central nervous system drugs, cardiovascular drugs, anti-diabetic drugs, oncology drugs, non-steroidal anti-inflammatory drugs (NSAIDs), and other drugs.
Region-wise, the global active pharmaceutical ingredients (APIs) market is segmented into Asia Pacific, North America, Europe, and Rest of the World (RoW). North America is the global leader in the active pharmaceuticals ingredients market due to its highly developed research and development projects in the field of therapies, medical sciences, and drugs. The R&D projects in this regional global active pharmaceuticals ingredients market are expected to help North America maintain its leadership during the forecasting horizon.
On the other hand, Asia Pacific is projected to be the most lucrative regional market in the global active pharmaceuticals ingredients (APIs) market. This region is marked by the presence of several generic medicine producers. This is expected to drive the Asia Pacific active pharmaceuticals ingredients market.
The companies operating in the global active pharmaceuticals ingredients (APIs) market are projected to tap into the opportunity presented by the patent expiry of bestselling biological drugs. Some of the key companies operating in the global active pharmaceuticals ingredients market are WuXi Apptec, Teva Pharmaceutical, Pfizer, Novartis, Mylan, BASF, Actavis, Cambrex, and Dr. Reddy’s Laboratories.
The global active pharmaceutical ingredients market is segmented into:
By Manufacturing Types
- Captive or In-house API manufacturing
- API contract manufacturing
By API Types
- Synthetic Chemical API
- Biological API
By Drug Types
- Branded or Innovative Prescription Drugs
- Generic Prescription Drugs
- Over-the-counter Drugs
By Therapeutic Area
- Non-steroidal Anti-inflammatory Drugs (NSAIDs)
- Oncology Drugs
- Anti-diabetic Drugs
- Cardiovascular Drugs
- Central Nervous System Drugs
- Musculoskeletal Drugs
- Other Drugs (antibacterial, antiviral, antifungal, etc.)
- North America
- Asia Pacific
- Rest of the World (RoW)
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
CONTACT: Mr. Nachiket Ghumare State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: firstname.lastname@example.org Website: http://www.transparencymarketresearch.com